MDX Medical, Inc., headquartered in the United States, is a prominent player in the medical technology industry, specialising in innovative diagnostic solutions. Founded in 2005, the company has established itself as a leader in the development of advanced medical devices and diagnostic tools, particularly in the fields of molecular diagnostics and point-of-care testing. With a strong operational presence across North America and Europe, MDX Medical is renowned for its commitment to enhancing patient care through cutting-edge technology. The company’s core products, including rapid diagnostic tests and laboratory equipment, are distinguished by their accuracy and ease of use, setting new standards in the healthcare sector. Recognised for its significant contributions to medical diagnostics, MDX Medical continues to push the boundaries of innovation, solidifying its market position as a trusted provider of essential healthcare solutions.
How does MDX Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
MDX Medical, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MDX Medical, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that MDX Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, MDX Medical's future climate commitments will be crucial for aligning with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MDX Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
